Xtant Medical Holdings Inc (XTNT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) has a cash flow conversion efficiency ratio of 0.106x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.38 Million) by net assets ($50.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Xtant Medical Holdings Inc for the company's overall valuation and market capitalisation.
Xtant Medical Holdings Inc - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Xtant Medical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Xtant Medical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xtant Medical Holdings Inc ranked by their cash flow conversion efficiency. Explore earnings quality score of Xtant Medical Holdings Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atlantic International Corp. Common Stock
NASDAQ:ATLN
|
-0.154x |
|
OptimumBank Holdings, Inc.
NYSE MKT:OPHC
|
0.052x |
|
Northwest Copper Corp
V:NWST
|
-5.572x |
|
Nice D&B Co. Ltd
KQ:130580
|
0.023x |
|
VenHub Global, Inc.
NASDAQ:VHUB
|
0.150x |
|
Sanko Pazarlama Ithalat Ihracat AS
IS:SANKO
|
0.077x |
|
Forian Inc
NASDAQ:FORA
|
0.108x |
|
Safety Shot Inc
NASDAQ:SHOT
|
-0.072x |
Annual Cash Flow Conversion Efficiency for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual cash flow conversion efficiency of Xtant Medical Holdings Inc from 2008 to 2025. View Xtant Medical Holdings Inc (XTNT) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $50.95 Million | $12.55 Million | 0.246x | +188.93% |
| 2024-12-31 | $42.96 Million | $-11.90 Million | -0.277x | -49.43% |
| 2023-12-31 | $51.35 Million | $-9.52 Million | -0.185x | -18.55% |
| 2022-12-31 | $34.17 Million | $-5.34 Million | -0.156x | -1199.56% |
| 2021-12-31 | $30.88 Million | $439.00K | 0.014x | +128.22% |
| 2020-12-31 | $14.51 Million | $-731.00K | -0.050x | -639.08% |
| 2019-12-31 | $-44.20 Million | $-413.00K | 0.009x | +133.74% |
| 2018-12-31 | $-43.77 Million | $1.21 Million | -0.028x | -399.22% |
| 2017-12-31 | $-58.70 Million | $-543.18K | 0.009x | -99.55% |
| 2016-12-31 | $-7.07 Million | $-14.41 Million | 2.037x | +298.69% |
| 2015-12-31 | $8.88 Million | $-9.10 Million | -1.025x | -208.83% |
| 2014-12-31 | $-7.77 Million | $-7.32 Million | 0.942x | -35.61% |
| 2013-12-31 | $-3.84 Million | $-5.62 Million | 1.463x | +157.37% |
| 2012-12-31 | $4.23 Million | $-10.79 Million | -2.550x | -90.53% |
| 2011-12-31 | $5.50 Million | $-7.36 Million | -1.338x | -109.90% |
| 2010-12-31 | $-619.24K | $-8.37 Million | 13.520x | +1825.08% |
| 2009-12-31 | $4.68 Million | $-3.67 Million | -0.784x | -123.00% |
| 2008-12-31 | $11.34K | $38.64K | 3.407x | -- |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more